Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy
This study has been completed.
Study NCT01150461   Information provided by Massachusetts General Hospital

First Received on June 22, 2010.   Last Updated on June 7, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypertrophic Cardiomyopathy
Additional conditions recognized in this trial
Cardiomyopathies
Cardiomyopathy, Hypertrophic
Hypertrophy
More general conditions related to this trial
Aortic Stenosis, Subvalvular
Aortic Valve Stenosis
Cardiovascular Diseases
Heart Diseases
Heart Valve Diseases
Pathological Conditions, Anatomical
Interventions listed in this trial
losartan
placebo
Additional drug interventions recognized in this trial
Angiotensin II
Angiotensin Receptor Antagonists
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Anti-Arrhythmia Agents
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
Massachusetts General Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services